Breaking News Instant updates and real-time market news.

NMR

Nomura

$5.14

0.06 (1.18%)

06:17
12/02/19
12/02
06:17
12/02/19
06:17

Nomura CEO Koji Nagai to be succeeded by Kentaro Okuda

Koji Nagai is stepping down as CEO of Nomura, the company said in a statement. As of April 1, he will be replaced by COO Kentaro Okuda. Nagai is expected to become Nomura's chairman. Reference Link

NMR Nomura
$5.14

0.06 (1.18%)

05/16/19
SBSH
05/16/19
DOWNGRADE
SBSH
Sell
Nomura downgraded to Sell from Neutral at Citi
Citigroup analyst Koichi Niwa downgraded Nomura Holdings to Sell from Neutral with a price target of 320 yen. The analyst sees a "grim" earnings environment for Nomura's domestic retail division and fixed income business. Further, Niwa believes is too optimistic that the operating environment will improve.
05/16/19
05/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Occidental Petroleum (OXY) downgraded to Hold from Buy at Argus with analyst Bill Selesky citing its confirmed purchase of Anadarko Petroleum (APC) for $76 per share and saying the company is overpaying for the assets with a bid well above that of Chevron's (CVX) $65 per share offer. 2. Nomura (NMR) downgraded to Sell from Neutral at Citi with analyst Koichi Niwa saying he sees a "grim" earnings environment for Nomura's domestic retail division and fixed income business. 3. Sito Mobile (SITO) downgraded to Hold from Buy at Lake Street with analyst Mark Argento citing the company's "big" Q1 miss and said he sees uncertainty around Sito Mobile's new product strategy and liquidity concerns in the near term. 4. The Stars Group (TSG) downgraded to Hold from Buy at Desjardins. 5. Roan Resources (ROAN) downgraded to In-Line from Outperform at Imperial Capital with analyst Irene Haas saying the company's Q1 earnings missed expectations due to well performance, ethane rejection, and weak NGL prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/31/19
JPMS
07/31/19
UPGRADE
JPMS
Neutral
Nomura upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Wataru Otsuka upgraded Nomura Holdings to Neutral from Underweight following the company's Q1 results.
07/31/19
JPMS
07/31/19
UPGRADE
JPMS
Neutral
Nomura upgraded to Neutral on earlier than expected progress at JPMorgan
As previously reported, JPMorgan analyst Wataru Otsuka upgraded Nomura Holdings to Neutral from Underweight following the company's Q1 results. Pretax profit rebounded sharply and topped his forecast, reported the analyst, who said the company's earnings recovery is clearer than he had expected. A shift to a more bullish rating would require further confirmation of this progress, said Otsuka, who raised his price target on Nomura shares to Y410 from Y400.

TODAY'S FREE FLY STORIES

GMAB

Genmab

, AZN

AstraZeneca

$48.19

0.23 (0.48%)

05:32
12/12/19
12/12
05:32
12/12/19
05:32
Downgrade
Genmab, AstraZeneca, Roche rating change  »

Genmab downgraded to Hold…

GMAB

Genmab

AZN

AstraZeneca

$48.19

0.23 (0.48%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Dec

  • 17

    Dec

WBA

Walgreens Boots Alliance

$58.00

-0.4 (-0.68%)

, MCK

McKesson

$143.40

0.59 (0.41%)

05:31
12/12/19
12/12
05:31
12/12/19
05:31
Hot Stocks
Walgreens Boots Alliance, McKesson create German wholesale JV »

Walgreens Boots Alliance…

WBA

Walgreens Boots Alliance

$58.00

-0.4 (-0.68%)

MCK

McKesson

$143.40

0.59 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

MTUAY

MTU Aero Engines

$0.00

(0.00%)

05:30
12/12/19
12/12
05:30
12/12/19
05:30
Downgrade
MTU Aero Engines rating change  »

MTU Aero Engines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

, HALO

Halozyme

$18.74

-0.46 (-2.40%)

05:30
12/12/19
12/12
05:30
12/12/19
05:30
Hot Stocks
Genentech says Phase III FeDeriCa study met primary endpoint »

Genentech, a member of…

RHHBY

Roche

$0.00

(0.00%)

HALO

Halozyme

$18.74

-0.46 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Dec

OEZVY

Verbund

$0.00

(0.00%)

05:28
12/12/19
12/12
05:28
12/12/19
05:28
Upgrade
Verbund rating change  »

Verbund upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALV

Autoliv

$83.17

0.81 (0.98%)

05:25
12/12/19
12/12
05:25
12/12/19
05:25
Upgrade
Autoliv rating change  »

Autoliv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AMGN

Amgen

$233.96

0.14 (0.06%)

05:25
12/12/19
12/12
05:25
12/12/19
05:25
Hot Stocks
Amgen, UCB announce EC approval of EVENITY »

Amgen and UCB announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$28.03

0.14 (0.50%)

05:25
12/12/19
12/12
05:25
12/12/19
05:25
Upgrade
Kroger rating change  »

Kroger upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$0.00

(0.00%)

05:23
12/12/19
12/12
05:23
12/12/19
05:23
Upgrade
BMW rating change  »

BMW upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHW

Charles Schwab

$49.60

0.43 (0.87%)

05:23
12/12/19
12/12
05:23
12/12/19
05:23
Upgrade
Charles Schwab rating change  »

Charles Schwab upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVKIF

Evonik

$0.00

(0.00%)

05:22
12/12/19
12/12
05:22
12/12/19
05:22
Upgrade
Evonik rating change  »

Evonik upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SOLVY

Solvay

$0.00

(0.00%)

05:22
12/12/19
12/12
05:22
12/12/19
05:22
Downgrade
Solvay rating change  »

Solvay downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SOLVY

Solvay

$0.00

(0.00%)

05:21
12/12/19
12/12
05:21
12/12/19
05:21
Upgrade
Solvay rating change  »

Solvay upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$86.59

0.56 (0.65%)

05:19
12/12/19
12/12
05:19
12/12/19
05:19
Upgrade
Starbucks rating change  »

Starbucks upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWI

SolarWinds

$18.28

0.1 (0.55%)

05:19
12/12/19
12/12
05:19
12/12/19
05:19
Recommendations
SolarWinds analyst commentary  »

SolarWinds remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAKE

Cheesecake Factory

$40.73

-0.77 (-1.86%)

05:14
12/12/19
12/12
05:14
12/12/19
05:14
Initiation
Cheesecake Factory initiated  »

Cheesecake Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXRH

Texas Roadhouse

$57.25

0.55 (0.97%)

05:13
12/12/19
12/12
05:13
12/12/19
05:13
Initiation
Texas Roadhouse initiated  »

Texas Roadhouse initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DRI

Darden

$117.44

-1.15 (-0.97%)

05:11
12/12/19
12/12
05:11
12/12/19
05:11
Initiation
Darden initiated  »

Darden initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

EAT

Brinker

$41.12

-0.225 (-0.54%)

05:09
12/12/19
12/12
05:09
12/12/19
05:09
Initiation
Brinker initiated  »

Brinker initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLMN

Bloomin' Brands

$21.95

-0.065 (-0.30%)

05:08
12/12/19
12/12
05:08
12/12/19
05:08
Initiation
Bloomin' Brands initiated  »

Bloomin' Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BEDU

Bright Scholar

$9.62

0.62 (6.89%)

05:05
12/12/19
12/12
05:05
12/12/19
05:05
Downgrade
Bright Scholar rating change  »

Bright Scholar downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$88.09

0.165 (0.19%)

04:59
12/12/19
12/12
04:59
12/12/19
04:59
Recommendations
Wayfair analyst commentary  »

Wayfair price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

MD

Mednax

$26.75

1.975 (7.97%)

04:56
12/12/19
12/12
04:56
12/12/19
04:56
Upgrade
Mednax rating change  »

Mednax upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCN

Waste Connections

$90.15

-0.03 (-0.03%)

04:55
12/12/19
12/12
04:55
12/12/19
04:55
Conference/Events
Waste Connections participates in a conference call with UBS »

Environmental Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

04:55
12/12/19
12/12
04:55
12/12/19
04:55
Conference/Events
JPMorgan software technology analyst to hold an analyst/industry conference call »

Software Technology…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.